Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apa/Enza Short Study in Low Volume Castration-sensitive Prostate Cancer
NCT07260435Phase 3Recruiting
- Start
- Feb 2024
- Primary completion
- Nov 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of apalutamide, enzalutamide in prostate cancer (PCa). Started Feb 2024; status: recruiting.
02
Drugs
apalutamideenzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07260435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260435.